Jump to main content
Jump to site search

All chapters
Previous chapter Next chapter

Chapter 11

A Clinically Relevant Case Study: the Development of Livatag® for the Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer in men (523 000 cases) and the seventh in women (226 000 cases). Most of the burden is in developing countries, where almost 85% of the cases occur, and particularly in men: the overall sex ratio male/female is around 4. High incidence r...

Publication details

Print publication date
30 Jul 2012
Copyright year
Print ISBN
From the book series:
Drug Discovery